Dimerix Limited logo
VerifiedPharmaceutical Manufacturing

Dimerix Limited

Dimerix (ASX:DXB) is a clinical-stage biopharmaceutical company with a portfolio of drug candidates for inflammatory diseases, including kidney and respiratory diseases. Dimerix’ lead clinical asset, DMX-200 (or QYTOVRA® in some territories), is in Phase 3 trials as a treatment for focal segmental glomerulosclerosis (FSGS), a rare kidney disease.

7-day free trial · no credit card

HeadquartersMelbourne, AustraliaEmployees21(1 to 10)Websitedimerix.comLinkedIn profileLinkedIn

Verified contacts

12

available on Kipplo

LinkedIn employees

21

1 to 10 range

Open roles

no listings

Distinct roles

9

indexed titles

Tech stack

1

tools in use

Monthly traffic

34

organic / mo

Sign up free to see all 12 verified contacts at Dimerix Limited

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

12 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Dimerix Limited

9 distinct titles indexed · top 9 shown.

  • 1account manager
  • 1associate clinical project manager
  • 1business development associate
  • 1clinical project associate
  • 1commercial operations senior manager
  • 1member board of directors
  • 1product development manager
  • 1senior clinical trial associate
  • 1vice president product development

Sign up to unlock all 12 contacts at Dimerix Limited

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 12 verified contacts at Dimerix Limited

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Dimerix Limited | Kipplo Discover